Post by Secarna Pharmaceuticals

Join our CEO Konstantin Petropoulos at #ASCO in Chicago! As we prepare for our first-in-human clinical study, we will present new preclinical and translational data for SECN-15 at the American Society of Clinical Oncology (ASCO) Annual Meeting.   🗓️ Poster Session Date & Time: May 30, 2026, 1:30 pm – 4:30 pm CDT (abstract no. 2613, poster board 403)   See our press release for more information [https://lnkd.in/djR4SxeF]